Conference abstractPublished 2019

Blue Faery helps liver cancer patients spread their wings

Authors: Andrea J Wilson

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

According to the European Respiratory Society, patient advocacy organizations serve three roles: support and advise others; make changes happen and provide the patient’s perspective. Blue Faery is the only non-profit corporation in the United States that specifically devoted to fighting primary liver cancer, especially Hepatocellular Carcinoma (HCC), the second most common cause of cancer deaths worldwide. Blue Faery’s mission is to prevent, treat and cure primary liver cancer through research, education and advocacy. Blue Faery has five key values that drive the organization: commitment to outstanding service to patients and caregivers; competence with high quality products; cost effectiveness and efficiency; conscientious collaboration and communication and transparency. These values ensure that the organization always puts its end users i.e. patients and caregivers above funders. Blue Faery supports and advises patients and caregivers through its educational materials, online community, one-onone peer support program and website that translates into nine languages specifically targeted at the HCC patient population. As a member of the Deadliest Cancers Coalition (DCC), Blue Faery works with other non-profits to make changes happen at the federal level. Most recently, the efforts of the DCC resulted in $2 billion increase for the National Institutes of Health (NIH) for FY2019. Blue Faery works with its partners in a number of ways to provide the patient’s perspective. From online surveys to in-person meetings, Blue Faery brings HCC patients, caregivers and survivors together to facilitate discussions about improving outcomes and increasing access to clinical trials. When patient advocacy groups serve patients and caregivers, they can make a major impact on the quality of life for patients and caregivers as well as on the visibility, funding, research and awareness of the disease.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.

Try:

More from this journal

The newest in Archives in Cancer Research.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalArchives in Cancer Research
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Andrea J Wilson”